Description
Kanamycin B is an aminoglycoside antibiotic that binds the bacterial 16s rRNA subunit, inhibiting translocation and degrading target RNA; it displays antibacterial efficacy against gram negative bacteria. Kanamycin also inhibits formation of the initiation complex. In cardiac pacemaker cells, kanamycin B decreases action potential amplitude, blocking slow Ca2+ currents and modulating outward K+ currents. Kanamycin B also inhibits mammalian RNA splicing.
References
Patwardhan A, Cowan JA. Influence of charge and structure on the coordination chemistry of copper aminoglycosides. Dalton Trans. 2011 Feb 28;40(8):1795-801. PMID: 21218243.
Aukema KG, Chohan KK, Plourde GL, et al. Small molecule inhibitors of yeast pre-mRNA splicing. ACS Chem Biol. 2009 Sep 18;4(9):759-68. PMID: 19634919.
Morales MA, Castrillon JL, Hernandez DA. Effects of bekanamycin and dibekacin on the electrical activity of cardiac pacemaker cells. Arch Med Res. 1993 Winter;24(4):339-45. PMID: 8118157.